Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 569

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 569
---
     |   | December 31, 
         2023 |   |
|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:--|--------------:|:--|:----|:--|-------------:|:--|
| Stockholders’ deficit:                                                                                                                                                                                                          |     |   |               |   |     |   |              |   |
| Common stock: $0.0001 par value – 40,000,000 authorized shares at September 30, 2024 and December 31, 2023, and 5,604,651 and 5,570,901 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively |     |   |             — |   |     |   |            — |   |
| Additional paid-in-capital                                                                                                                                                                                                      |     |   |         5,748 |   |     |   |        5,732 |   |
| Accumulated deficit                                                                                                                                                                                                             |     |   |      (122,706 | ) |     |   |     (115,728 | ) |
| Total stockholders’ deficit                                                                                                                                                                                                     |     |   |      (116,958 | ) |     |   |     (109,996 | ) |
| Total liabilities, convertible preferred stock and stockholders’ deficit                                                                                                                                                        |     | $ |         2,527 |   |     | $ |        1,893 |   |

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-53

PROFUSA, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)

|                                                                                                                                               |     | Nine Months Ended September 30, |      2024 |   |     |   |      2023 |   |
|:----------------------------------------------------------------------------------------------------------------------------------------------|:----|:--------------------------------|----------:|:--|:----|:--|----------:|:--|
| Government grant revenue                                                                                                                      |     | $                               |       100 |   |     | $ |        30 |   |
| Operating expenses:                                                                                                                           |     |                                 |           |   |     |   |           |   |
| Research and development                                                                                                                      |     |                                 |     1,349 |   |     |   |     1,467 |   |